We just received data on a new analyst forecast for $CHRD. Mark Lear from Piper Sandler set a price target of 160.0 for CHRD.
To track analyst ratings and price targets for $CHRD, check out Quiver Quantitative's $CHRD forecast page.
Should you buy $CHRD?
Some analysts are better than others. To view the past performance of Piper Sandler, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CHRD Price Targets
Multiple analysts have issued price targets for $CHRD recently. We have seen 10 analysts offer price targets for $CHRD in the last 6 months, with a median target of $121.5.
Here are some recent targets:
- Mark Lear from Piper Sandler set a target price of $160.0 on 01/28/2026
- Hanwen Chang from Wells Fargo set a target price of $109.0 on 01/27/2026
- Devin McDermott from Morgan Stanley set a target price of $114.0 on 01/23/2026
- Scott Gruber from Citigroup set a target price of $97.0 on 01/14/2026
- Scott Hanold from RBC Capital set a target price of $128.0 on 01/13/2026
- Josh Silverstein from UBS set a target price of $119.0 on 01/09/2026
- Nitin Kumar from Mizuho set a target price of $150.0 on 12/12/2025
$CHRD Insider Trading Activity
$CHRD insiders have traded $CHRD stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CHRD stock by insiders over the last 6 months:
- SHANNON BROWNING KINNEY (EVP, CAO, GC & Corp Secretary) has made 0 purchases and 2 sales selling 4,019 shares for an estimated $419,933.
- SAMANTHA HOLROYD purchased 1,250 shares for an estimated $106,875
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHRD Revenue
$CHRD had revenues of $1.3B in Q3 2025. This is a decrease of -9.54% from the same period in the prior year.
You can track CHRD financials on Quiver Quantitative's CHRD stock page.
$CHRD Congressional Stock Trading
Members of Congress have traded $CHRD stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CHRD stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CHRD Hedge Fund Activity
We have seen 209 institutional investors add shares of $CHRD stock to their portfolio, and 236 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOSTON PARTNERS removed 1,815,287 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $180,385,069
- FMR LLC added 1,359,203 shares (+27.2%) to their portfolio in Q3 2025, for an estimated $135,064,002
- ORION PORFOLIO SOLUTIONS, LLC removed 704,175 shares (-99.3%) from their portfolio in Q3 2025, for an estimated $69,973,869
- CITADEL ADVISORS LLC removed 515,620 shares (-98.8%) from their portfolio in Q3 2025, for an estimated $51,237,159
- POINT72 ASSET MANAGEMENT, L.P. removed 471,370 shares (-87.4%) from their portfolio in Q3 2025, for an estimated $46,840,036
- ENCOMPASS CAPITAL ADVISORS LLC added 391,777 shares (+inf%) to their portfolio in Q3 2025, for an estimated $38,930,880
- SIR CAPITAL MANAGEMENT, L.P. removed 377,585 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $37,520,621
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
